Clin2
NCT07311811Likely a fitNot yet recruiting

Study of two new drugs in healthy volunteers

Healthy Volunteers

This study tests two investigational drugs in healthy adults to see how the body absorbs, breaks down, and eliminates them, and to check for any side effects. If you are a healthy adult, you may be able to help researchers understand these drugs better.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
60 people
Ages
19 years to 59 years
Study type
Interventional

Who can take part

  • You are between 19 and 59 years old.
  • Your body mass index (BMI) is between 18 and 30, and you weigh at least 50 kg (men) or 45 kg (women).
  • You are generally healthy, with no significant chronic diseases.
  • You agree to use a reliable non-hormonal birth control method (like an IUD, tubal ligation, vasectomy, or abstinence) from the first dose until 14 days after the last dose, and you will not donate sperm or eggs during that time.
  • You have not donated whole blood in the last 8 weeks, nor participated in another drug study in the last 6 months.
  • You have no history of stomach or bowel surgery (except for appendix or hernia surgery).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07674940Recruiting· Phase 1
Study of a new drug at different doses in healthy people

This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.

Miramar, Florida
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah
NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT07765706Recruiting· Phase 1
Testing an investigational medicine in healthy volunteers

This study tests a new medicine called INS1033 in healthy people to see if it is safe and how the body handles it. It is an early-stage study and does not involve treating any disease.

Salt Lake City, Utah
NCT07748702Not yet recruiting· Phase 1
Study of a new drug in healthy volunteers

This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.

Seoul
NCT07297693Not yet recruiting· Phase 1
Comparing two versions of a medication in healthy adults

This trial compares two different forms of a medication to see how they are absorbed and processed by the body and to check that they are safe. It is an early-stage study in healthy volunteers.

Seoul, Gwanak-gu

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.